Manage Your Liver
Q:

Understanding NAFLD – What are the available diagnosing methods and treatment options?

Understanding NAFLD – What are the available diagnosing methods and treatment options?
A:

Being the leading cause of chronic liver diseases in the USA and Europe, Non-alcoholic Fatty Liver Disease (NAFLD) is gradually becoming a common health issue worldwide. According to a recent research, the global prevalence of NAFLD is estimated to be 24%, with South America and the Middle East having the highest rates of NAFLD patients. 

NAFLD refers to the accumulation of excess fat in the liver of people who only drink little or no alcohol, and there’s a huge correlation between the disease and obesity. Often known as the “silent killer”, NAFLD is difficult to be diagnosed in the early stages because of its asymptomatic nature. 

 

Current diagnosing methods for NAFLD

Since NAFLD does not have much symptoms shown in the early stages, most of the time it is suspected in overweight or obese patients who have mild elevations of liver enzymes in their routine blood tests. Imaging studies such as liver ultrasound can also help diagnose NAFLD by seeing if the patient has accumulation of fat in the liver. 

The most accurate way of detecting NAFLD is a liver biopsy as it provides all the essential information for diagnosis. While it is the most reliable way, doctors don’t usually recommend it since NAFLD is an early stage of liver disease.

In this case, does it mean patients need to wait until when the disease progresses to later stages to be able to do something about it?

 

Possible new biomarker for NAFLD

A recent study conducted by a team of researchers from Britain, Italy, Spain, and France have found that the raised levels of a compound, named phenylacetic acid (PAA) that is released by a certain type of gut bacteria, was linked to the excess fat build-up in the liver and also the early onset of NAFLD. 

The group compared the medical data of 100 women who were diagnosed with NAFLD and obesity but without diabetes with that of a group of healthy individuals and came up with such findings. This research result suggests that PAA could be considered as a new NAFLD biomarker, making early diagnosis of NAFLD just one simple blood test away.

It was also noticed that as NAFLD advanced, the gut microbiome (gut bacteria environment) became poorer and less diverse. While there is definitely a strong link between the development of NAFLD and a poor gut microbiome (raised levels of PAA in this case), it is still unclear which is the cause and which is the effect. But nonetheless, this study definitely opened a new possibility for future clinical research on the early diagnosis of NAFLD by targeting the gut microbiome.

 

Treatments for NAFLD

When NAFLD is not diagnosed or treated, there is a chance of the disease developing into cirrhosis or even liver cancer. Even though not a majority of patients would have their simple fatty liver disease progressed to cirrhosis, patients should always be careful when they are diagnosed with NAFLD. Aside from losing weight, taking natural liver supplements that have proven anti-inflammatory properties can also help bring liver function back to normal, thereby reducing the chance of NAFLD progressing into something much more serious.

 

If you have any questions regarding how we can help restore your liver health, please do not hesitate to contact our support team for more information about liver protection.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Known as an epidemic silent killer, non-alcoholic fatty liver diseases (NAFLD) affects 25.2% of the global population.  While it is clear that alcohol should be completely avoided for individuals with severe liver diseases such as cirrhosis and liver cancer, currently there is no guideline in suggesting alcoholic use for patients with NAFLD. Since more than one-third of the US adult population is affected by NAFLD and approximately two-thirds consume alcohol, one might wonder i
A:
While there are a lot of diseases in the world that have direct cures, there are still diseases which scientists and doctors have yet to find the remedies in the West, and non-alcoholic steatohepatitis (NASH) is one of them.   What is NASH? NASH is a type of non-alcoholic fatty liver disease (NAFLD). Different from simple fatty liver disease, patients with NASH do not just have fat built in the liver, but also have inflammation and liver cel
Hit Questions
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.